And another momo dream of fast riches bites the dust. And not even a single margin hike was required. The reason: huge revenue miss, with top line coming at $26.3 million on estimates of $41.7 million. EPS are obviously irrelevant in this context. Additionally, Molycorp says that Japan may hurt market demand in Q2 and Q3... BUT... it sees demand fully recovering by Q4. Press release was likely drafted by Jean Claued Junker and edited by the Wall Street Journal. In other news, one still can't eat Praseodymium.
No comments yet! Be the first to add yours.